An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection
M Romero-Navarrete, LF Ruíz, A Castillo… - Journal de Mycologie …, 2018 - Elsevier
Chromoblastomycosis is defined as a chronic cutaneous and subcutaneous fungal infection
caused by melanized or brown-pigmented fungi. A 63-year-old man farmer showed on …
caused by melanized or brown-pigmented fungi. A 63-year-old man farmer showed on …
Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam
TA Le, KL Nguyen, MH Pham, TT Vi, NA Do - Mycopathologia, 2019 - Springer
Background Chromoblastomycosis is a chronic fungal infection of the skin and
subcutaneous tissues caused by different melanized fungi. The disease occurs worldwide …
subcutaneous tissues caused by different melanized fungi. The disease occurs worldwide …
Chromoblastomycosis caused by Fonsecaea monophora in Mexico
P Campos-Macias, R Arenas, CJ Aquino… - Journal of Medical …, 2021 - Elsevier
Chromoblastomycosis is a chronic subcutaneous fungal infection caused by melanized
fungi. It is usually an occupational mycosis affecting people in rural areas in tropical and …
fungi. It is usually an occupational mycosis affecting people in rural areas in tropical and …
[HTML][HTML] Chromoblastomycosis–A clinical mimic of squamous carcinoma
Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue
caused by dematiaceous fungi. We report a case of chromoblastomycosis caused by …
caused by dematiaceous fungi. We report a case of chromoblastomycosis caused by …
Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole
AE Paniz-Mondolfi, MT Colella, DC Negrin… - Medical …, 2008 - academic.oup.com
Chromoblastomycosis is a chronic infection caused by dematiaceous (dark-colored) fungi
which affect the skin and subcutaneous tissues, and is characterized by a wide variety of …
which affect the skin and subcutaneous tissues, and is characterized by a wide variety of …
Extensive Chromoblastomycosis of the Leg Secondary to Fonsecaea pedrosoi
AI Mourad, RM Haber - Journal of cutaneous medicine and …, 2022 - journals.sagepub.com
Chromoblastomycosis is a deep fungal infection that favors the lower extremities often
following trauma. A 27-year-old female presented with a long history of a 12-cm pigmented …
following trauma. A 27-year-old female presented with a long history of a 12-cm pigmented …
Hidden under a Cauliflower‐Like Skin Tumor: Chromoblastomycosis
B Jakopp, B Stamm, D Eyer… - Case reports in infectious …, 2013 - Wiley Online Library
We present the case of an 80‐year‐old patient with a recurrent hyperpigmented and
cauliflower‐like skin tumor on the stump of his left index finger. Despite suggestive clinical …
cauliflower‐like skin tumor on the stump of his left index finger. Despite suggestive clinical …
[HTML][HTML] Chromoblastomycosis Caused by Fonsecaea monophora Mimicking Lichen Planus
Y Oprea, T Stringer, D Mattis, B Amin, R Mann - Cureus, 2024 - ncbi.nlm.nih.gov
Chromoblastomycosis is a rare fungal infection acquired by traumatic inoculation of
pigmented fungi from an environmental source. The polymorphic presentation of …
pigmented fungi from an environmental source. The polymorphic presentation of …
Chromoblastomycosis caused by Fonsecaea monophora
BS KIM, JH CHOI, SH SOHNG… - Korean Journal of …, 2014 - pesquisa.bvsalud.org
Chromoblastomycosis is a chronic subcutaneous mycotic infections caused by
dermatiaceous fungi. Clinically, chromoblastomycosis presents frequently with erythematous …
dermatiaceous fungi. Clinically, chromoblastomycosis presents frequently with erythematous …
Chromoblastomycosis: a clinical and molecular study of 18 cases in Rio de Janeiro, Brazil
MF Mouchalouat… - International journal …, 2011 - Wiley Online Library
Background Chromoblastomycosis (CBM) is a chronic subcutaneous mycosis caused by
dematiaceous fungi. Methods We described epidemiological data, clinical presentation, and …
dematiaceous fungi. Methods We described epidemiological data, clinical presentation, and …